Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

RLS Global AB Interim Report Q2, 2019

April 1st - June 30th ·  Net sales amounted to SEK 0.5 million (0.4), a revenue growth of 25 percent ·  Earnings before interest and taxes (EBIT) amounted to SEK -5.8 million (-6.3) ·  Earnings per share after dilution at SEK -0.10 (-0.11) ·  Cash flow from operating activities amounted to SEK -6.3 million (-4.9) ·  Liquid assets at the end of the period at SEK 8.3 million (34.5) ·  Equity ratio was 82 percent (86) January 1st - June 30th · Net sales amounted to SEK 0.7 million (0.5), a revenue growth of 38 percent · Earnings before interest and taxes (EBIT)

Teleste's financial reporting and Annual General Meeting in 2020

TELESTE CORPORATION   STOCK EXCHANGE RELEASE   15.8.2019   AT 09:30 EET TELESTE'S FINANCIAL REPORTING AND ANNUAL GENERAL MEETING IN 2020 During the year 2020, Teleste Corporation will publish financial information as follows: February 13, 2020 - Financial Statements Bulletin for 2019May 15, 2020 - Interim report for January-March 2020August 13, 2020 - Half year financial report for January-June 2020October 29, 2020 - Interim report for January-September 2020 The Annual Report for 2019 will be published at www.teleste.com during week 11/2020. Teleste Corporation's Annual

Vestas - Interim financial report, second quarter 2019

Vestas Wind Systems A/S, Aarhus, 15 August 2019Company announcement No. 13/2019 Revenue and earnings decreased compared to last year’s second quarter while free cash flow improved. Highest ever quarterly order intake and combined order backlog at all-time high level. Guidance for 2019 narrowed.  In the second quarter of 2019, Vestas generated revenue of EUR 2,121m – a decrease of 6 percent compared to the year-earlier period. EBIT before special items decreased by EUR 131m to EUR 128m. The EBIT margin was 6.0 percent compared to 11.5 percent in the second quarter of 2018 and free

Allan Junge-Jensen, Chief Financial Officer (CFO) and co-founder, to leave Boozt AB

Allan Junge-Jensen, Chief Financial Officer and co-founder has decided to leave Boozt AB by the end of January 2020 to pursue a career outside Boozt.Allan Junge-Jensen has been with Boozt since 2011, when he joined the company as CFO. Allan was part of the team relaunching Boozt in 2011 and thereby founding Boozt.com as a multi-brand platform and the company as it is known today. “I have truly enjoyed my time at Boozt. It has been very rewarding on both a professional and personal level with numerous great experiences. I am proud of the company we have created, and I leave the company in

Humana appoints Anu Kallio as Country Manager of Humana in Finland

Humana Group appoints Anu Kallio as the new Country Manager of Humana in Finland. Kallio comes with a deep understanding and solid experience from the social care sector in Finland and will start in her new role no later than 1stof March 2020.- Having a country manager with the breadth and depth of Anu’s industry experience is great for Humana. This, combined with her personal drive and motivation, will greatly support the achievement of our strategic plans. We warmly welcome Anu to Humana, says Rasmus Nerman, President and CEO of Humana.- I am very excited about the possibility to join

Boozt AB’s Half year report, January 1 – June 30 2019

Net revenue growth of 26% (local currency 25%) in the second quarter with 21% growth in Boozt.com and 156% growth in Booztlet.com. The adjusted EBIT margin increased to 5.2% (4.9%). For the first six months net revenue growth was 27% (local currency 26%) with an adjusted EBIT margin of 2.2% (2.4%).SEK million unless Apr 1 – Apr 1 –   Change Jan 1 – Jan 1 –   Changeotherwise Jun 30, Jun 30, Jun 30, Jun 30,indicated  2019 2018 2019 2018GROUP            Net

Last Patient In for landmark PMDD study

Asarina Pharma AB (publ) (ASAP: FN Stockholm) today announced the last patient was enrolled in the Phase IIb study for its first-in-class compound Sepranolone for premenstrual dysphoric disorder (PMDD). Top-line results are on track for late March 2020.“This is a crucial milestone. Full enrolment means we are on track to deliver top-line results in late March 2020 as promised. It also shows how large the unmet need and market potential is. PMDD is a devastating disorder afflicting 1-in-20 women of reproductive age worldwide,” said CEO Peter Nordkild.   Sepranolone reduced key symptoms by

Invitation to a press conference: Kamux Corporation’s Half Year Financial Report for January—June 2019

Kamux Corporation    Investor News    15 August, 2019 at 9:00 Invitation to a press conference: Kamux Corporation’s Half Year Financial Report for January—June 2019 Kamux Corporation will publish its Half Year Financial Report for January—June 2019 on Friday, 23 August 2019 at about 9:00 a.m. Kamux will hold a Half Year Financial Report press conference for media and analysts on August 23, 2019 at hotel GLO Kluuvi, Video Wall meeting room, address Kluuvikatu 4, Helsinki, at 11:00 (Finnish time) in Finnish and then in English at around 11:30. You can follow the press conference

Isofol Announces Management Team Evolution with Appointment of Dr. Roger Tell as Chief Medical Officer

GOTHENBURG, Sweden, August 15, 2019 – Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL), today announced the appointment of Roger Tell, M.D., Ph.D. as Chief Medical Officer (CMO), in addition to his responsibilities as Chief Scientific Officer (CSO). Former CMO Karin Ganlöv, M.D. will transition her role to Senior Medical Director with focus on safety and regulatory at Isofol. This transition in responsibilities is part of the next step in the evolution of the Isofol management team leveraging Dr. Tell's expertise in medical oncology and the biopharma industry to oversee

InDex Pharmaceuticals Holding AB (publ) interim report January – June 2019

Last patient enrolled in the CONDUCT studyPeriod April – June 2019   ·  Revenues amounted to SEK 0.0 (0.0) million ·  Operating result amounted to SEK –17.7 (–26.0) million ·  Result after tax amounted to SEK –17.7 (–26.0) million, corresponding to SEK –0.26 per share (–0.42) before and after dilution ·  Cash flow from operating activities amounted to SEK –13.9 (–19.7) million Period January – June 2019 ·  Revenues amounted to SEK 0.0 (0.1) million ·  Operating result amounted to SEK –34.9 (–44.7) million ·  Result after tax amounted to SEK –34.9 (–44.7) million,

Global Gaming 555 AB – Interim report January – June 2019

Second Quarter, April - June 2019 · Revenue for the period amounted to SEK 132.2 (227.8) million. · Operating profit was SEK -11.1 (41.0) million. · Operating profit before non-recurring write-downs SEK 0.5 (41.0) million. · Profit after tax for the period was SEK -11.8 (28.9) million, or SEK -0.29 (0.71) per share.  · Cash flow from operations for the period amounted to SEK -16.8 (39.4) million. · The Swedish Gambling Authority revoked our subsidiary SafeEnt Ltd’s  Swedish licences for online gambling and betting. The decision has been appealed to the Administrative

Appointments at Keliber

Kai Helkiö (Construction Manager), who started as a Construction Project Director for Keliber Oy's Lithium Project in June, has been appointed as a member of the company's Management Group. Helkiö is responsible for organizing the construction project, selection of the key suppliers, schedule of the construction project and safety and environmental aspects of the project. Helkiö reports to the CEO of the company. Chief Production Officer of Keliber, Manu Myllymäki (Master of Science, Technology), has been appointed as a Chief Operating Officer (COO) of the company responsible for the

TC TECH Sweden AB (publ) publishes its interimreport as of June 30th, 2019

TC TECH has today published its interim report for the period January 1 to June 30, 2019.Net sales amounted to 4 254 (0) TSEK in the second quarter of 2019. In the same period, net profit/loss totalled -6 838 (-7 557) TSEK. Cash flow from operating activities was -9 270 (-6 164) TSEK in the second quarter of 2019.  Net sales amounted to 5 118 (0) TSEK in the first half of 2019, while net profit/loss totalled -15 372 (-15 222) TSEK. Cash flow from operating activities was -15 947 (-11 210) TSEK in the period from 1 January to 30 June 2019.  · TC TECH Sweden AB (publ) announced that

Interim Report April-June 2019: High iron ore prices lift LKAB

In the second quarter net sales increased by 50 percent to MSEK 9,233 (6,160) compared with the same period last year, while operating profit was boosted to MSEK 4,116 (931). The quarter was characterised by very good market conditions and a continued focus on ensuring future competitiveness.Sales for the first half increased by 34 percent year-on-year, while operating profit was boosted by 166 percent to MSEK 6,629 (2,492). The improved earnings are mainly attributable to higher iron ore prices and a strong US dollar. Somewhat lower delivery volumes in the first quarter had a negative

PainDrainer AB appoints Anki Malmborg Hager as new CEO – mission to lead the eHealth expansion

PainDrainer AB has since 2018 developed the first web-based application for self-management of chronic pain improving the quality of life by giving individual prognosis on how to minimize the pain level through artificial intelligence.  In the US and in Europe there are around 190 million people suffering from chronic pain and over $900 billion are spent in healthcare costs. Anki Malmborg Hager has a long-standing experience of leading life science companies in their early start-up phases, with SenzaGen being the most recent and successful achievement. Anki Malmborg Hager will start as CEO on

Revenio Group Corporation: Half-year financial report, 1.1.-30.6.2019

Revenio Group Corporation, Stock Exchange Release, August 15, 2019 at 9.00Revenio Group Corporation: Half-year financial report H1/2019:  Figures in brackets refer to the same period in the previous year, unless otherwise stated. Revenio acquired the entire share capital of Italian company CenterVue SpA at the end of April, 2019. The purchase price of EUR 59 million was paid in cash, for which Revenio had secured debt financing subject to customary conditions. In addition, the parties agreed on an arrangement whereby Revenio will pay an additional purchase price of EUR 1 million if

Stora Enso shares converted

STORA ENSO OYJ STOCK EXCHANGE RELEASE 15 August 2019 at 9.00 EESTDuring the 1–31 July 2019 conversion period there was one conversion and a total of 172 A shares were converted into R shares. The shares were recorded in the Finnish trade register today, 15 August 2019, and trading in the new R shares will start on 16 August 2019.Breakdown of shares after conversion: A shares 176 258 264R shares 612 361 723Total 788 619 987 Each A share and each ten R shares carry one vote. The total amount of votes after the conversion is at least 237 494 436.For further information,

Sedana Medical enters India – signs Indian distributor

Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced a distribution agreement with the Indian distributor Hansraj Nayyar Medical. Sales will commence in the fall and a registration process will start in parallel. Hansraj Nayyar has committed to a first framework order of 25,000 euros. The Indian market potential for sedation in intensive care is estimated to be around two million ventilation days annually."Hansraj Nayyar is a pioneer in Indian intensive care and it is very gratifying that they will now launch our therapy." said Christer Ahlberg, CEO of Sedana Medical. Under

NCC to build new Burlövsbadet

NCC and the Municipality of Burlöv will build the new Burlövsbadet swimming center in Arlöv, just north of Malmö. The assignment is a construction partnering project and the order value is SEK 290 million.“Together with NCC, we have found a solution that both meets the municipality’s future requirements and is sustainable. The new swimming center will play a very important role in making Burlöv attractive and in the development of Kronetorpstaden, which is now growing between Arlöv and Åkarp. The railways extension between Lund and Arlöv, featuring four tracks at the new Burlöv

Read original

ContextVision - Second quarter saw commercial release of first AI-based product, Altumira™, Digital Pathology on track and record sales

STOCKHOLM – August 15, 2019 – ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, continued to advance its artificial intelligence portfolio in the second quarter 2019. The company’s AI-based product Altumira™ for X-ray is now commercially available and INIFY Prostate for digital pathology will soon move to beta testing in several pathology labs. Q2 sales reached 23,1 MSEK, record sales for second quarter, 5,5% higher than Q2 2018. The operating result was positive 5,4 MSEK, mainly due to higher capitalization for product

Systemair acquires company in Australia

Press Release, August 15, 2019 Systemair AB (NASDAQ OMX Stockholm: SYSR) has acquired the ventilation part of the Australian company Pacific HVAC Engineering. The company, which is headquartered in Melbourne, has an annual turnover of approximately AUD 20 million (SEK 130 million) and is also established in Sydney, Adelaide, Brisbane, Perth, and Auckland in New Zealand. The company is a distributor of ventilation products and manufactures a range of fans. The number of employees is 60 people and the company will be renamed Pacific Ventilation immediately. "We see great opportunities

Nixu published its H12019 results - Growth of 32 percent with good profitability

Nixu Corporation Press release, August 15, 2019 at 8.35 AM EESTCybersecurity company Nixu has published today its Half-Year Financial Report, which is available on the company’s website https://www.nixu.com/H12019. Petri Kairinen, Nixu CEO, comments on the results, “I’m very pleased with our first half and especially with the combination of our profitability and growth. The overall growth of 32% keeps us on a strong path to growth.”Kairinen continues, “I’m very proud of the progress we made during the spring. The year began with particularly strong organic growth, with the main driver

There are no items matching the current filter
There are no more items matching the current filter
Back to top